These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 4765722)

  • 1. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C; Lima AO; Andrade LM; Mattos O
    Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy.
    Bullock WE; Fields JP; Brandriss MW
    N Engl J Med; 1972 Nov; 287(21):1053-9. PubMed ID: 4562439
    [No Abstract]   [Full Text] [Related]  

  • 3. Disturbance of the blood T:B lymphocyte ratio in lepromatous leprosy. Clinical and immunologic correlations.
    Dwyer JM; Bullock WE; Fields JP
    N Engl J Med; 1973 May; 288(20):1036-9. PubMed ID: 4540496
    [No Abstract]   [Full Text] [Related]  

  • 4. Isopathic phenomenon in lepromatous leprosy. A reappraisal.
    Job CK
    Int J Lepr Other Mycobact Dis; 1969; 37(4):365-71. PubMed ID: 5394257
    [No Abstract]   [Full Text] [Related]  

  • 5. The Kveim test in lepromatous and tuberculoid leprosy.
    Pearson JM; Pettit JH; Siltzbach LE; Ridley DS; Hart PD; Rees RJ
    Int J Lepr Other Mycobact Dis; 1969; 37(4):372-81. PubMed ID: 5394258
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional lymph node involvement in tuberculoid leprosy.
    Apte DC; Zawar M; Mehta MC; Zawar PB; Chawhan RN
    Lepr India; 1983 Oct; 55(4):680-5. PubMed ID: 6668925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the immunological effects of cimetidine in patients with lepromatous leprosy.
    Brown AE; Nelson KE; Makonkawkeyoon S; Vithayasai V; Scollard DM; Bullock WE
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):559-64. PubMed ID: 3910745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of cellular hypersensitivity in leprosy, using the lymphocyte migration inhibition test].
    Del rey Calero J; Calbo Torrecillas F
    Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1319-32. PubMed ID: 5525221
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of reactions to leprolin and lepromin in patients with lepromatous leprosy by the transfer factor.
    Han SH; Tsai LC; Hu SC; Loo ST
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):1-8. PubMed ID: 7004800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cell mediated immune responses in untreated cases of leprosy.
    Talwar GP; Krishnan AD; Mehra VL; Blum EA; Pearson JM
    Clin Exp Immunol; 1972 Oct; 12(2):195-203. PubMed ID: 4567646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A.
    Beck JS; Morley SM; Gibbs JH; Potts RC; Ilias MI; Kardjito T; Grange JM; Stanford J; Brown RA
    Clin Exp Immunol; 1986 Jun; 64(3):484-94. PubMed ID: 3539419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of macrophage inhibitory factor by patients with leprosy.
    Katz SI; DeBetz BH; Zaias N
    Arch Dermatol; 1971 Apr; 103(4):358-61. PubMed ID: 5091865
    [No Abstract]   [Full Text] [Related]  

  • 15. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response in two groups of anergic patients to the transfer of leukocytes from sensitive donors.
    Rodriguez Paradisi E; De Bonaparte YP; Morgenfeld MC
    N Engl J Med; 1969 Apr; 280(16):859-61. PubMed ID: 4887076
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of cell mediated immunity in leprosy: changing trends in the immunological spectrum of the disease.
    Saha K; Mittal MM
    Clin Exp Immunol; 1971 Jun; 8(6):901-9. PubMed ID: 5091616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune deficit in patients with lepromatous leprosy: its nature and relation to genetic factors, spectrum, and duration of the illness.
    Saha K; Agarwal SK
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):1-6. PubMed ID: 571846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated lepromin testing on experimental nine-banded armadillo leprosy.
    Job CK; Sanchez RM; Hastings RC
    Indian J Lepr; 1985; 57(4):716-27. PubMed ID: 3915005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.